Novo Nordisk to Rebrand as Novo

Dow Jones09-14 16:28

Wegovy maker Novo Nordisk said it is rebranding as Novo, as the Danish drugmaker prepares to give a strategy update later this month.

The company said Monday that its new corporate identity with the single Novo name aims to make it more recognizable and consistent in the way it reaches people to compete in an increasingly consumer-driven market for obesity medications.

"'Novo' will be used as the name of the company day-to-day, while Novo Nordisk A/S remains the legal global company name," it said.

The company said it would emphasize competitiveness in its corporate culture going forward. The rebrand and shift in culture are part of changes Novo plans to introduce to deliver on its business objectives, it added.

Novo has scheduled an event with investors for Sept. 21, when it expects to provide an update on its new corporate strategy.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2667365962?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-09-14 16:28","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2667365962","market":"fut","top_or_hot":-1,"title":"Novo Nordisk to Rebrand as Novo","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<pre style=\"white-space: pre\">\n \n</pre>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Wegovy maker Novo Nordisk said it is rebranding as Novo, as the Danish drugmaker prepares to give a strategy update later this month. \n</p>\n<p>\n  The company said Monday that its new corporate identity with the single Novo name aims to make it more recognizable and consistent in the way it reaches people to compete in an increasingly consumer-driven market for obesity medications. \n</p>\n<p>\n  \"'Novo' will be used as the name of the company day-to-day, while Novo Nordisk A/S remains the legal global company name,\" it said. \n</p>\n<p>\n  The company said it would emphasize competitiveness in its corporate culture going forward. The rebrand and shift in culture are part of changes Novo plans to introduce to deliver on its business objectives, it added. \n</p>\n<p>\n  Novo has scheduled an event with investors for Sept. 21, when it expects to provide an update on its new corporate strategy. \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<pre style=\"white-space: pre\">\n \n</pre>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Novo Nordisk to Rebrand as Novo</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNovo Nordisk to Rebrand as Novo\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2026-09-14 16:28</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<pre style=\"white-space: pre\">\n \n</pre>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Wegovy maker Novo Nordisk said it is rebranding as Novo, as the Danish drugmaker prepares to give a strategy update later this month. \n</p>\n<p>\n  The company said Monday that its new corporate identity with the single Novo name aims to make it more recognizable and consistent in the way it reaches people to compete in an increasingly consumer-driven market for obesity medications. \n</p>\n<p>\n  \"'Novo' will be used as the name of the company day-to-day, while Novo Nordisk A/S remains the legal global company name,\" it said. \n</p>\n<p>\n  The company said it would emphasize competitiveness in its corporate culture going forward. The rebrand and shift in culture are part of changes Novo plans to introduce to deliver on its business objectives, it added. \n</p>\n<p>\n  Novo has scheduled an event with investors for Sept. 21, when it expects to provide an update on its new corporate strategy. \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<pre style=\"white-space: pre\">\n \n</pre>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"NVOX","symbol_name":"2倍做多NVO ETF-Defiance","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2667365962","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2667365962","pubTimestamp":1789374480,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"Wegovy maker Novo Nordisk said it is rebranding as Novo, as the Danish drugmaker prepares to give a strategy update later this month.The company said Monday that its new corporate identity with the single Novo name aims to make it more recognizable and consistent in the way it reaches people to compete in an increasingly consumer-driven market for obesity medications.\"'Novo' will be used as the name of the company day-to-day, while Novo Nordisk A/S remains the legal global company name,\" it said.The company said it would emphasize competitiveness in its corporate culture going forward. The rebrand and shift in culture are part of changes Novo plans to introduce to deliver on its business objectives, it added.Novo has scheduled an event with investors for Sept. 21, when it expects to provide an update on its new corporate strategy.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"NVOX":"2倍做多NVO ETF-Defiance","LU0154236417.USD":"BGF US FLEXIBLE EQUITY \"A2\" ACC","LU1093756325.SGD":"FTIF - Franklin K2 Alt Strat Fd A (acc) SGD-H1","BK4007":"制药","BK4588":"碎股","NVOC":"Corgi NVO 2x Daily ETF","BK4585":"ETF&股票定投概念","PPH":"VanEck Pharmaceutical ETF","THNR":"AMPLIFY WEIGHT LOSS DRUG & TREATMENT ETF","NVOH":"Novo Nordisk A/S B Shares ADRhedged","BK4599":"减肥药","BK4532":"文艺复兴科技持仓","LU1093756168.USD":"FRANKLIN K2 ALTERNATIVE STRATEGIES \"A\" (USD) ACC","OZEM":"Roundhill GLP-1 & Weight Loss ETF","NVO":"诺和诺德","IE00BKVL7J92.USD":"Legg Mason ClearBridge - US Equity Sustainability Leaders A Acc USD","IE00BZ1G4Q59.USD":"LEGG MASON CLEARBRIDGE US EQUITY SUSTAINABILITY LEADER \"A\"(USD) INC (A)"},"translate_title":"诺和诺德将更名为诺和诺德","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"THNR":0.6,"OZEM":0.6,"NVOX":0.6,"PPH":0.6,"NVOH":0.6,"NVOC":0.6,"NVO":1.96},"content_text":"Wegovy maker Novo Nordisk said it is rebranding as Novo, as the Danish drugmaker prepares to give a strategy update later this month. \n\n\n  The company said Monday that its new corporate identity with the single Novo name aims to make it more recognizable and consistent in the way it reaches people to compete in an increasingly consumer-driven market for obesity medications. \n\n\n  \"'Novo' will be used as the name of the company day-to-day, while Novo Nordisk A/S remains the legal global company name,\" it said. \n\n\n  The company said it would emphasize competitiveness in its corporate culture going forward. The rebrand and shift in culture are part of changes Novo plans to introduce to deliver on its business objectives, it added. \n\n\n  Novo has scheduled an event with investors for Sept. 21, when it expects to provide an update on its new corporate strategy.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":true,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.50.0","shortVersion":"4.50.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2667365962","isCrawlerRequest":true}